Summary

Cases of multidrug-resistant tuberculosis (MDR-TB) are increasing. MDR complicates therapy and results in lower success rates and higher mortality, especially in HIV coinfected patients. This article discusses the conundrum of MDR-TB and combination therapy and ways to address it.